REMEDY : BNSSG referral pathways & Joint Formulary


Home > Formulary : Paediatric > Paediatric Chapters > 4. Nervous system >

BNSSG Paediatric Joint Formulary

4.6 Sleep disorders

Last edited: 06-09-2024

4.6.1 Insomnia

First line drugs Second line drugs Specialist drugs Secondary care drugs

 

Before a hypnotic is prescribed the underlying cause should be identified and addressed, and realistic sleep requirements should be discussed with the patient.

Promethazine (TLS Green)

Chloral hydrate (TLS Red)

Melatonin modified-release and immediate-release (TLS Amber 3 months)

  • Intrinsic sleep disorder with one of:
    • Autism Spectrum Disorder (ASD) diagnosis,
    • Learning Disability (LD) diagnosis,
    • a neurodevelopmental disorder / disability (e.g. cerebral palsy) (excluding those with Attention Deficit Hyperactivity Disorder as a standalone diagnosis)
  • Shared Care Protocol

 

Melatonin (TLS Red)

  • For use on PICU and paediatric HDU (during hospital stay only) to aid onset of sleep in patients with neurodevelopmental disorders/ASD and other conditions e.g. bone marrow transplant and renal patients who are suffering from sleep cycle disorder following prolonged stays and who have not responded to standard sleep hygiene measures.

 

4.6.2 Narcolepsy

Modafinil (TLS Red)

Sodium oxybate (TLS Red)